Business
PANTHERx® Rare Selected by Insmed to Dispense BRINSUPRI™ (brensocatib) for the Treatment of Non-Cystic Fibrosis Bronchiectasis
PANTHERx® Rare Pharmacy, a leader in rare disease product patient access and support services in the United States, announced that it was selected by Insmed as part of the network of specialty pharmacies to dispense BRINSUPRI™ (brensocatib), a once daily oral medication to treat non-cystic fibrosis bronchiectasis (NCFB) in adults and pediatric patients 12 years and older.1 2
About this update from Insmed Incorporated
[{"type":"text","content":"PITTSBURGH, Aug. 13, 2025 /PRNewswire/ -- PANTHERx® Rare Pharmacy, a leader in rare disease product patient access and support services in the United States, announced that it was selected by Insmed as part of the network of specialty pharmacies to dispense BRINSUPRI™ (brensocatib), a once daily oral medication to treat non-cystic fibrosis bronchiectasis (NCFB) in adults and pediatric patients 12 years and older.1 2","length":429,"tagName":"p"},{"type":"image","alt":"PANTHERx Rare is the nation's leading rare disease pharmacy. We exist for people living with rare and orphan diseases who deserve the best that medicine can offer. (PRNewsfoto/PANTHERx Rare)","displaySize":"","headline":null,"caption":"PANTHERx Rare is the nation's leading rare disease pharmacy. We exist for people living with rare and orphan diseases who deserve the best that medicine can offer. (PRNewsfoto/PANTHERx Rare)","className":"","disableSlideshowImg":false,"size":{"original":{"width":400,"height":204,"url":"https://media.zenfs.com/en/prnewswire.com/ef5ff408c8afa7e6c3d246d5acfc1fab"},"resized":{"url":"https://s.yimg.com/ny/api/res/1.2/rdDfQB7RxEdzKYzwev3B4Q--/YXBwaWQ9aGlnaGxhbmRlcjt3PTcwNTtoPTM2MDtjZj13ZWJw/https://media.zenfs.com/en/prnewswire.com/ef5ff408c8afa7e6c3d246d5acfc1fab","width":400,"height":204}},"href":"https://mma.prnewswire.com/media/955325/PANTHERx_Rare_Logo.html","hrefExternal":true,"rel":"nofollow"},{"type":"text","content":""The PANTHERx team is pleased to be chosen by Insmed to dispense BRINSUPRI™, the first and only FDA-approved treatment for NCFB," said Bansi Nagji, CEO, PANTHERx® Rare Pharmacy.","length":187,"tagName":"p"},{"type":"text","content":"About PANTHERx RarePANTHERx Rare is a specialty pharmacy exclusively focused on rare and orphan diseases, distributing several orphan products, and providing access and support services to those needing them most. Known as The Rare Disease Pharmacy®, PANTHERx transforms lives by delivering medicine breakthroughs, clinical excellence, and access solutions to people living with rare and devastating conditions.","length":417,"tagName":"p"},{"type":"text","content":"PANTHERx is a dual-accredited specialty pharmacy, holding distinctions in rare disease including the Accreditation Commission for Health Care (ACHC) Distinction in Orphan Drugs and Utilization Review Acc...